Lack of mda-6/WAF1/CIP1-mediated inhibition of cyclin-dependent kinases in interferon-α resistant murine B16 melanoma cells

Previously we demonstrated that IFN-α augments mda-6/WAF1 and inhibits cyclin-dependent kinases in a p53-independent fashion in B16 murine melanoma cells. On the other hand, IFN-γ activates p53 expression without affecting the mda-6/WAF1 system. Combination of the two IFNs is additive. B16 cells acq...

Full description

Saved in:
Bibliographic Details
Published inCancer letters Vol. 119; no. 2; pp. 237 - 240
Main Authors Aranya, Istvan, Fleischmann, Christina M., Tyring, Stephen K., Fleischmann, W.Robert
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 11.11.1997
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Previously we demonstrated that IFN-α augments mda-6/WAF1 and inhibits cyclin-dependent kinases in a p53-independent fashion in B16 murine melanoma cells. On the other hand, IFN-γ activates p53 expression without affecting the mda-6/WAF1 system. Combination of the two IFNs is additive. B16 cells acquire IFN-α resistant but IFN-γ sensitive phenotype after long term IFN-α treatment (B16α cells). Here we demonstrate the absence of mda-6/WAF1-associated repression of cyclindependent kinases, but the existence of p53-dependent c- myc inhibition in IFN-γ-treated B16α cells. Clearly, selective desensitization of IFN-α related growth regulation does not influence the IFN-γ associated pathway. Our results further support the coexistence of distinct growth regulatory mechanisms in B16 cells that can be activated by different IFN-types independently of each other.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0304-3835
1872-7980
DOI:10.1016/S0304-3835(97)00288-7